Rosh Psychiatry Board Practice Exam 2025 - Free Psychiatry Board Practice Questions and Study Guide

The main pharmacological treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) is stimulant medications, such as methylphenidate. These medications are considered first-line treatments due to their effectiveness in reducing core symptoms of ADHD, including inattention, hyperactivity, and impulsivity. Stimulant medications work primarily by increasing the levels of certain neurotransmitters in the brain, namely dopamine and norepinephrine, which are known to play key roles in attention and behavior regulation.

Methylphenidate, as well as amphetamines, have shown robust efficacy in improving focus and reducing hyperactive and impulsive behaviors in both children and adults diagnosed with ADHD. The choice of stimulant can be based on individual response and tolerability, but the overall success rate of these medications in managing ADHD symptoms is well-supported by numerous studies.

Other medication classes mentioned, such as atypical antipsychotics, SSRIs, and MAOIs, are not primarily indicated for ADHD. Atypical antipsychotics may be used in cases where comorbid conditions are present, but they do not target ADHD symptoms directly. SSRIs are typically used for anxiety and depression, and MAOIs have limited use in modern psychiatry, primarily for atyp